Melatonin enhances the anticonvulsant and proconvulsant effects of morphine in mice: Role for nitric oxide signaling pathway

Epilepsy Research

Volumn 75, Issue 2-3, 2007, Pages 138-144

  Yahyavi Firouz Abadi, Noushin ^a,b   Tahsili Fahadan, Pouya ^a,b   Riazi, Kiarash ^a   Ghahremani, Mohammad Hossein ^b   Dehpour, Ahmad R ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Clonic seizure threshold; Melatonin; Mice; Morphine; Nitric oxide; Pentylenetetrazole

Indexed keywords

MELATONIN; MORPHINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD;

ANIMALS; ANTICONVULSANTS; ANTIOXIDANTS; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; MALE; MELATONIN; MICE; MORPHINE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SEIZURES; SIGNAL TRANSDUCTION;

EID: 34447293289     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2007.05.002     Document Type: Article

References (55)

1. Acuna-Castroviejo D., Escames G., Macias M., Munoz Hoyos A., Molina Carballo A., Arauzo M., and Montes R. Cell protective role of melatonin in the brain. J. Pineal Res. 19 (1995) 57-63
2. G-nitro-l-arginine methyl ester. Life Sci. 52 (1993) 245-249
3. Albertson T.E., Peterson S.L., Stark L.G., Lakin M.L., and Winters W.D. The anticonvulsant properties of melatonin on kindled seizures in rats. Neuropharmacology 20 (1981) 61-66
4. Bettahi I., Pozo D., Osuna C., Reiter R.J., Acuna-Castroviejo D., and Guerrero J.M. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J. Pineal Res. 20 (1996) 205-210
5. Borowicz K.K., Kaminski R., Gasior M., Kleinrok Z., and Czuczwar S.J. Influence of melatonin upon the protective action of conventional anti-epileptic drugs against maximal electroshock in mice. Eur. Neuropsychopharmacol. 9 (1999) 85-90
6. Bredt D.S., Hwang P.M., and Snyder S.H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347 (1990) 768-770
7. Brignola G., Calignano A., and Di Rosa M. Modulation of morphine antinociception in the mouse by endogenous nitric oxide. Br. J. Pharmacol. 113 (1994) 1372-1376
8. Brzezinski A. Melatonin in humans. N. Engl. J. Med. 336 (1997) 186-195
9. Buisson A., Lakhmeche N., Verrecchia C., Plotkine M., and Boulu R.G. Nitric oxide: an endogenous anticonvulsant substance. Neuroreport 4 (1993) 444-446
10. Champney T.H., Hanneman W.H., Legare M.E., and Appel K. Acute and chronic effects of melatonin as an anticonvulsant in male gerbils. J. Pineal Res. 20 (1996) 79-83
11. Chang H.M., Ling E.A., Chen C.F., Lue H., Wen C.Y., and Shieh J.Y. Melatonin attenuates the neuronal NADPH-d/NOS expression in the nodose ganglion of acute hypoxic rats. J. Pineal Res. 32 (2002) 65-73
12. Chuchuen U., Ebadi M., and Govitrapong P. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis. J. Pineal Res. 37 (2004) 223-229
13. Coto-Montes A., Masson-Pevet M., Pevet P., and Moller M. The presence of opioidergic pinealocytes in the pineal gland of the European hamster (Cricetus cricetus): an immunocytochemical study. Cell Tissue Res. 278 (1994) 483-491
14. Czeisler C.A. Commentary: evidence for melatonin as a circadian phase shifting agent. J. Biol. Rhythms 12 (1997) 618-626
15. Dambisya Y.M., and Lee T.L. Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br. J. Pharmacol. 117 (1996) 914-918
16. Dawson D., and Encel N. Melatonin and sleep in humans. J. Pineal Res. 15 (1993) 1-12
17. Ebadi M., Govitrapong P., Phansuwan-Pujito P., Nelson F., and Reiter R.J. Pineal opioid receptors and analgesic action of melatonin. J. Pineal Res. 24 (1998) 193-200
18. Esposti D., Esposti G., Lissoni P., Parravicini L., and Fraschini F. Action of morphine on melatonin release in the rat. J. Pineal Res. 5 (1988) 35-39
19. Foote F., and Gale K. Morphine potentiates seizure induced by GABAantagonists and attenuates seizures induced by electroshock in the rat. Eur. J. Pharmacol. 95 (1983) 259-264
20. Frederickson R.C.A., Burgis V., and Edwards J.D. Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli. Science 198 (1977) 756-758
21. Gale K. Subcortical structures and pathways involved in convulsive seizure generation. J. Clin. Neurophysiol. 9 (1992) 264-277
22. Geffard M., Gaffori O., Chauveau J., Muyard J.P., and Le Moal M. Dramatic increase in pineal melatonin levels in the rat after subcutaneous injection of des-tyrosine1-gamma-endorphin. Neurosci. Lett. 27 (1981) 329-334
23. Golombek D.A., Pevet P., and Cardinali D.P. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci. Biobehav. Rev. 20 (1996) 403-412
24. Gupta M., Gupta Y.K., Agarwal S., Aneja S., and Kohli K. A randomized, double-blind, placebo controlled trial of melatonin add-on therapy in epileptic children on valproate monotherapy: effect on glutathione peroxidase and glutathione reductase enzymes. Br. J. Clin. Pharmacol. 58 (2004) 542-547
25. Homayoun H., Khavandgar S., Namiranian K., Gaskari S.A., and Dehpour A.R. The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res. 48 (2002) 33-41
26. Kaputlu I., and Uzbay T. L-NAME inhibits pentylenetetrazole and strychnine-induced seizures in mice. Brain Res. 753 (1997) 98-101
27. Kavaliers M., Hirst M., and Teskey G.C. Ageing, opioid analgesia and the pineal gland. Life Sci. 32 (1983) 2279-2287
28. G-nitro-l-arginine prevents morphine tolerance. Eur. J. Pharmacol. 221 (1992) 399-400
29. Lakin M.L., Miller C.H., Stott M.L., and Winters W.D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sci. 29 (1981) 2543-2551
30. Lauretti G.R., Ahmad I., and Pleuvry B.J. The activity of opioid analgesics in seizure models utilizing N-methyl-d-aspartic acid, kainic acid, bicuculline and pentylenetetrazole. Neuropharmacology 33 (1994) 155-160
31. Lewczuk B., Przybylska-Gornowicz B., and Wyrzykowski Z. The effect of morphine on melatonin secretion in the domestic pig: in vivo and in vitro study. Neuroendocrinol. Lett. 20 (1999) 171-178
32. Longo V.G., Massoti M., and Sagratella S. Convulsant drugs and changes in the electrical activity of the brain: an investigation of the effects of opioids on chemoconvulsions. Prog. Clin. Biol. Res. 124 (1983) 121-128
33. Löscher, Honack W., Fassbender D., and Nolting C.P.B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs III. Pentylenetetrazole seizure models. Epilepsy Res. 8 (1991) 171-189
34. Mevissen M., and Ebert U. Anticonvulsant effects of melatonin in amygdale-kindeled rats. Neurosci. Lett. 257 (1998) 13-16
35. Molina-Carballo A., Munoz-Hoyos A., Reiter R.J., Sanchez-Forte M., Moreno-Madrid F., Rufo-Campos M., Molina-Font J.A., and Acuna-Castroviejo D. Utility of high doses of melatonin as adjunctive anticonvulsant therapy in a child with severe myoclonic epilepsy: two years' experience. J. Pineal Res. 23 (1997) 97-105
36. Molina-Carballo A., Munoz-Hoyos A., Rodriguez-Cabezas T., and Acuna-Castroviejo D. Day-night variations in melatonin secretion by the pineal gland during febrile and epileptic convulsions in children. Psychiatry Res. 52 (1994) 273-283
37. Moller M., Mikkelsen J.D., and Phansuwan-Pujito P. Demonstration of nerve fibers immunoreactive to met-enkephalin and b-endorphin in the bovine pineal gland. Role of Melatonin and Pineal Peptides. In: Fraschini F., and Reiter R.J. (Eds). Neuroimmunomodulation (1991), Plenum Press, New York 15-25
38. Moncada S., and Higgs E.A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
39. Moore R.Y., and Sibony P. Enkephalin-like immunoreactivity in neurons in the human pineal gland. Brain Res. 457 (1988) 395-398
40. Mulsch A., Busse R., Mordvintcev P.I., Vanin A.F., Nielsen E.O., Scheel-Kruger J., and Olesen S.P. Nitric oxide promotes seizure activity in kainate-treated rats. Neuroreport 5 (1994) 2325-2328
41. Munoz-Hoyos A., Sanchez-Forte M., Molina-Carballo A., Escames G., Martin-Medina E., Reiter R.J., Molina-Font J.A., and Acuna-Castroviejo D. Melatonin's role as an anticonvulsant and neural protector: experimental and clinical evidence. J. Child Neurol. 13 (1998) 501-509
42. Nidhi G., Balakrishnan S., and Pandhi P. Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats. Methods Find Exp. Clin. Pharmacol. 21 (1999) 609-612
43. Osonoe K., Mori N., Suzuki K., and Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res. 663 (1994) 338-340
44. Pozo D., Reiter R.J., Calvo J.R., and Guerrero J.M. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci. 55 (1994) PL455-PL460
45. Raghavendra V., and Kulkarni S.K. Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur. J. Pharmacol. 409 (2000) 279-289
46. Schapel G.J., Beran R.G., Kennaway D.L., McLoughney J., and Matthews C.D. Melatonin response in active epilepsy. Epilepsia 36 (1995) 75-78
47. Schroder H., Weihe E., Nohr D., and Vollrath L. Immunohistochemical evidence for the presence of peptides derived from proenkephalin, prodynorphin and proopiomelanocortin in the guinea pig pineal gland. Histochemistry 88 (1988) 333-341
48. Starr M.S., and Starr B.S. Paradoxical facilitation of pilocarpineinduced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol. Biochem. Behav. 45 (1993) 321-325
49. Swinyard E.A., and Kupferberg H.J. Antiepileptic drugs: detection, quantification, and evaluation. Fed. Proc. 44 (1985) 2629-2633
50. Theard M.A., Baughman V.L., Wang Q., Pelligrino D.A., and Albrecht R.F. The role of nitric oxide in modulating brain activity and blood flow during seizure. Neuroreport 6 (1995) 921-924
51. Udenfriend S., and Kilpatrick D.L. Proenkephalin and products of its processing: chemistry and biology. In: Udenfriend S., and Meinhofer J. (Eds). Analysis, Synthesis, Biology (1984), Academic Press, New York 25-68
52. Vuolteenaho O., Vakkuri O., and Leppaluoto J. Wide distribution of beta-endorphin-like immunoreactivity in extrapituitary tissues of rat. Life Sci. 27 (1980) 57-65
53. Wan Q., Man H.Y., Liu F., Braunton J., Niznik H.B., Pang S.F., Brown G.M., and Wang Y.T. Differential modulation of GABAA receptor function by Mel1a and Mel1b receptors. Nat. Neurosci. 2 (1999) 401-403
54. Yahyavi-Firouz-Abadi N., Tahsili-Fahadan P., Riazi K., Ghahremani M.H., and Dehpour A.R. Involvement of nitric oxide pathway in the acute anticonvulsant effect of melatonin in mice. Epilepsy Res. 68 (2006) 103-113
55. Yu C.X., Wu G.C., Xu S.F., and Chen C.H. Melatonin influences the release of endogenous opioid peptides in rat periaqueductal gray. Sheng Li Xue Bao 52 (2000) 207-210